International Congress of Traumatologists and Orthopedists "Artromost 2022"

On November 26, 2022, Fidia Russia took part in the International Congress of Traumatologists and Orthopedists "Artromost 2022".
More than 200 traumatologists from Russian cities, as well as foreign colleagues attended the event.
The products of Fidia Pharma, a leader in the development and production of hyaluronic acid for intra-articular injection, aroused great interest among the participants of the event.
At the company's stand, doctors could get the latest scientific data confirming the effectiveness and safety of Fidia's products (Hyalone, Hymovis, Hyalubrix, Hyalganbio), as well as ask clarifying questions to the company's employees.

Farmaceutici S.p.A.

Find out our Corporate Website:

Go to the website

Key Business Areas

Drawing on the strengths of the parent company, Fidia Pharma Russia product portfolio focalizes primarily on joint healthcare.

Fidia Pharma Russia is focused on providing consumers with innovative products that offer quality, safety and performance.